RARA and acute promyelocytic leukemia: In addition to the standard cytogenetic methods, such as conventional karyotyping and FISH, which are routinely used to detect PML::RARA fusions in APL patients, optical genome mapping (OGM) is an emerging technology for characterizing genome-wide SVs.